Abstract
Abundant evidence has been presented to indicate that phospho-ribosylpyrophosphate (PRPP) is the rate-limiting substrate for purine synthesis de novo (for review, see ref.1). Cultured cells derived from patients with purine overproduction have increased intracellular PRPP concentrations resulting from either increased PRPP synthesis or diminished PRPP utilization in alternative pathways (2–5). PRPP synthesis is catalyzed by PRPP synthetase (E.C. 2.7.6.1). Several distinct superactive forms of this enzyme have been described in association with increased PRPP generation and increased rates of purine synthesis de novo (3–6). Among these mutant forms of PRPP synthetase are enzymes with: increased maximal velocity of the reaction but normal sensitivity to purine nucleotide inhibition of enzyme activity (7); normal maximal velocity but altered regulatory properties (3, 6); both altered catalytic and regulatory properties (8).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
M.A. Becker, in Uric acid, Handbook of Experimental Pharmacology Vol. 51 (W.N. Kelley and I.M. Weiner, editors) Springer-Verlag Berlin 1978, p155.
F.M. Rosenbloom, J. F. Henderson, I.C. Caldwell, W.N. Kelley, and J.E. Seegmiller, J.Biol.Chem. 243:1166 (1968).
E. Zoref, A. de Vries, and O. Sperling, J.Clin.Invest. 56: 1093 (1975).
M.A. Becker, J.J. Meyer, A.W. Wood, and J.E. Seegmiller, Science 179:1123 (1973).
M.A. Becker, J.Clin.Invest. 57:308 (1976).
O. Sperling, P. Boer, S. Persky-Brosh, E. Kanarek and A. de Vries, Rev.Eur.Etud.Clin.Biol. 17:703 (1972).
M.A. Becker, P.J. Kostel, and L.J. Meyer, J.Biol.Chem. 250: 6822 (1975).
M.A. Becker, K.O. Raivio, B. Bakay, W.B. Adams, and W.L. Nyhan, These proceedings.
C.D. Green, and D.W. Martin, Jr. Proc.Natl.Acad.Sci. 70: 3698 (1973).
J.F. Henderson, and M.K.Y. Khoo, J.Biol.Chem. 240:3104 (1965).
E. Zoref, A. de Vries, O. Sperling, Hum.Hered. 27:73 (1977).
K.O. Raivio, and J.E. Seegmiller, Biochim.Biophys.Acta 299: 283 (1973).
P.S. Chen, T.Y. Toribara, and H. Warner, Anal.Chem. 28: 1756 (1956).
M.S. Hershfield, F.F. Snyder, and J.E. Seegmiller, Science 197:1284 (1977).
I.C. Caldwell, J.F. Henderson, and A.R.P. Paterson, Can.J. Biochem. 44:229 (1966).
M.A. Becker, L.J. Meyer, and J.E. Seegmiller, Am.J.Med. 55: 232 (1973).
G. Planet, and I.H. Fox, J.Biol.Chem. 251:5839 (1976).
M.S. Hershfield, and J.E. Seegmiller, Adv.Exp.Med.Biol. 76A:19 (1976).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Plenum Press, New York
About this chapter
Cite this chapter
Yen, R.C.K., Becker, M.A. (1980). Methylmercaptopurine Ribonucleoside Toxicity in Human Fibroblasts: Inhibition of Phosphoribosylpyrophosphate Synthetase as Well as Amidophosphoribosyltransferase. In: Rapado, A., Watts, R.W.E., De Bruyn, C.H.M.M. (eds) Purine Metabolism in Man—III. Advances in Experimental Medicine and Biology, vol 122B. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8559-2_24
Download citation
DOI: https://doi.org/10.1007/978-1-4684-8559-2_24
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-8561-5
Online ISBN: 978-1-4684-8559-2
eBook Packages: Springer Book Archive